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Ovarian cancer relapse is often characterized by metastatic spread throughout the peri-
toneal cavity with tumors attached to multiple organs. In this study, interaction of ovarian
cancer cells with the peritoneal tumor microenvironment was evaluated in a xenograft
model based on intraperitoneal injection of fluorescent SKOV3.ip1 ovarian cancer cells.
Intra-vital microscopy of mixed GFP-red fluorescent protein (RFP) cell populations injected
into the peritoneum demonstrated that cancer cells aggregate and attach as mixed
spheroids, emphasizing the importance of homotypic adhesion in tumor formation. Elec-
tron microscopy provided high resolution structural information about local attachment
sites. Experimental measurements from the mouse model were used to build a three-
dimensional cellular Potts ovarian tumor model (OvTM) that examines ovarian cancer cell
attachment, chemotaxis, growth, and vascularization. OvTM simulations provide insight
into the relative influence of cancer cell–cell adhesion, oxygen availability, and local archi-
tecture on tumor growth and morphology. Notably, tumors on the mesentery, omentum, or
spleen readily invade the “open” architecture, while tumors attached to the gut encounter
barriers that restrict invasion and instead rapidly expand into the peritoneal space. Simula-
tions suggest that rapid neovascularization of SKOV3.ip1 tumors is triggered by constitutive
release of angiogenic factors in the absence of hypoxia.This research highlights the impor-
tance of cellular adhesion and tumor microenvironment in the seeding of secondary ovarian
tumors on diverse organs within the peritoneal cavity. Results of the OvTM simulations
indicate that invasion is strongly influenced by features underlying the mesothelial lining at
different sites, but is also affected by local production of chemotactic factors.The integrated
in vivo mouse model and computer simulations provide a unique platform for evaluating
targeted therapies for ovarian cancer relapse.
Keywords: ovarian cancer, tumor modeling, tumor microenvironment, metastasis, cellular Potts model, cell
adhesion, angiogenesis, chemotaxis
INTRODUCTION
Ovarian cancer is often detected at a late stage of disease after
the cancer has locally disseminated to the peritoneum. Visible
tumors are surgically removed and residual microscopic disease
is targeted with chemotherapy. However, 90% of patients who
originally respond to treatment will relapse with chemotherapy-
resistant disease (McGuire et al., 1996). Relapse is thought to
occur because residual cancer cells aggregate in the peritoneal fluid
and form microscopic tumor spheroids that are more resistant
to chemotherapy (Shield et al., 2009). These spheroids can then
adhere to the surface of organs in the peritoneum and seed new
tumors, encouraged by chemokines and growth factors within the
peritoneal fluid (Milliken et al., 2002; Bast et al., 2009).
A common feature of the peritoneal environment is the
mesothelial lining that cancer cells must sequentially bind to (Stro-
bel and Cannistra, 1999; Casey et al., 2001; Kenny et al., 2008) and
penetrate (Burleson et al., 2006; Iwanicki et al., 2011) in order to
adhere to underlying tissues. Recent in vitro studies suggest that
this penetration step can occur within a few hours after spheroid
attachment (Iwanicki et al., 2011). Nevertheless, unique features
associated with different organs clearly influence progression in
this disease. For example, ovarian cancer cells preferentially col-
onize the omentum, a fatty tissue that has pockets of resident
immune cells referred to as “milky spots” and easily accessible
blood vessels (Gerber et al., 2006; Khan et al., 2010; Nieman et al.,
2011). Cancer cells also colonize other organs in the peritoneum,
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with distinct growth rates and morphology depending on the
site. It is reasonable to expect that these heterogeneous tumor
populations will respond differently to treatment, motivating fur-
ther investigation into the features of the microenvironment that
govern these differences.
To establish a mouse model of ovarian cancer relapse,
SKOV3.ip1 cells expressing fluorescent proteins [GFP, red flu-
orescent protein (RFP)] were injected into the peritoneum of
nude mice and the resulting tumors growing on the omentum,
intestine, mesentery, and spleen were imaged. Excised tumors
were processed for both transmission and light microscopy, pro-
viding detailed information about the cellular environment and
vascularization patterns.
The distinct features in tumor morphology at different sites
led us to consider the potential contributions of local chemotactic
factors, oxygenation and adhesion through mathematical mod-
eling. In recent years, mathematical models have moved beyond
the generic models of tumor growth and development (e.g., Jiang
et al., 2005; Shirinifard et al., 2009; Morton et al., 2011; Giverso
and Preziosi, 2012) and are now able to realistically model cancers,
e.g., breast cancer (Chauviere et al., 2010; Macklin et al., 2012) and
colon cancer (Dunn et al., 2012). Few have addressed the unique
features of ovarian cancer. Arakelyan et al. (2005) modeled ovar-
ian tumor growth response to the dynamics of vascular density
and vessel size (Arakelyan et al., 2005). Giverso et al. (2010) devel-
oped a two-dimensional model of early ovarian tumor spheroid
invasion through the mesothelium and underlying extracellular
matrix (ECM) (Giverso et al., 2010).
In the present work, our focus is on understanding the dis-
tinct features of tumor morphology at different sites in ovarian
cancer relapse in three dimensions. The cellular Potts model
framework was chosen because of its previous successes in study-
ing similar problems in tumor growth and angiogenesis (Jiang
et al., 2005; Shirinifard et al., 2009). Our cell-based and geomet-
rically realistic ovarian tumor model (OvTM), takes into account
characteristics of the peritoneal microenvironment and provides
insight into the earliest steps in spheroid attachment, invasion, and
vascularization within the peritoneum. In particular, homotypic
and heterotypic adhesion observed between SKOV3.ip1 xenograft
cancer cells and the niche tissue structure are the starting point of
OvTM. We applied the model to explore the roles of cell adhesion,
cell migration and proliferation as influenced by the microenvi-
ronment at two sites and were able to reproduce experimental
observations. The ultimate goal of our model is a realistic repre-
sentation of spheroid growth, whose dimensions and morphology
qualitatively resemble the tumors disseminated in different tissue
niches in the peritoneal cavity in our mouse xenografts. Such a
model can be further developed to include short-term drug deliv-
ery after debulking surgery, allowing the evaluation of local drug
responsiveness.
MATERIALS AND METHODS
CELL CULTURE AND CELL LINES
SKOV3.ip.1 parental cells and GFP-stable transfectants were kind
gifts of Laurie Hudson and Angela Wandinger-Ness (UNM).
This aggressive line was passaged through a nude mouse (Yu
et al., 1993). Cells were maintained in RPMI-1640 medium
supplemented with 5% heat-inactivated FBS, 1% l-glutamine,
1% sodium pyruvate, and 0.5% penicillin/streptomycin (Invitro-
gen, Grand Island, NY, USA). SKOV3.ip1-GFP cells were treated
with 250µg/ml hygromycin to maintain GFP expression. To cre-
ate RFP-expressing SKOV3.ip1 cells, parental cells were trans-
fected with the pTagRFP-N vector (Axxora, San Diego, CA, USA)
using Lipofectamine LTX reagent (Invitrogen). Stably fluorescent
cells were selected with geneticin sulfate (Invitrogen) for 1 week.
Transfectants were sorted for high fluorescence using a Beckman
Coulter Legacy MoFlo cell sorter (UNM Flow Cytometry Core
Facility).
INTRAPERITONEAL MOUSE MODEL OF OVARIAN CANCER RELAPSE
All mouse procedures were approved by the University of New
Mexico Animal Care and Use Committee, in accordance with NIH
guidelines for the Care and Use of Experimental Animals.
Nu/nu nude mice (NCI) or nude mice ubiquitously express-
ing RFP (Anticancer Inc., San Diego, CA, USA) (Yang et al., 2009)
were engrafted by intraperitoneal injection with 100µl of a single
cell suspension containing five million SKOV3.ip1 cells express-
ing GFP. Tumor adhesion and invasion was assessed at 4 days and
2 weeks post-injection. For low magnification assessment of total
tumor burden, eight nude mice were imaged using a Pan-A-See-Ya
Panoramic Imaging System (Lightools, Inc., Encinitas, CA, USA)
2 or 3 weeks post-injection of SKOV3.ip GFP cells. For improved
resolution images (up to 16×, single cell resolution), mice were
imaged on the OV100 Olympus whole mouse imaging system
(Olympus Corp., Tokyo, Japan) at AntiCancer, Inc., San Diego,
CA, USA, as previously reported (Yamauchi et al., 2006).
Where described, sections of intestine and attached mesentery
with tumors were excised (Fu and Hoffman, 1993) and fixed in
zinc fixative for 30 min (Howdieshell et al., 2011). Samples were
mounted on glass slides with ProLong Gold mounting media
(Invitrogen). GFP fluorescence and brightfield images were col-
lected on a Nikon TE2000 Microscope (UNM Microscopy Core
Facility) using an Axiocam digital color camera and SlideBook
Image Acquisition software.
CO-INJECTION EXPERIMENTS
SKOV3.ip1-GFP cells and SKOV3.ip1-RFP cells (2.5× 106 each
population) were harvested from culture by trypsinization and
mixed together as a single cell suspension immediately before
injecting a total of five million cells into the peritoneum of three
nude mice. For consecutive injections, 2.5 million SKOV3.ip1-GFP
cells were injected IP into three nude mice followed by injection
of 2.5 million SKOV3.ip1-RFP cells a week later. The mice were
sacrificed at the end of week 2 and tumors were imaged on the
OV100.
HISTOLOGY AND IMMUNOFLUORESCENCE
Mouse tumors were fixed in formalin or zinc fixative, embed-
ded in paraffin, sectioned and hematoxylin/eosin (H&E) stained
by TriCore (Albuquerque, NM, USA) or processed for immuno-
fluorescence using anti-CD31 antibodies (BD Biosciences, San
Jose, CA, USA). Images were acquired on a Zeiss AxioSkop or
LSM500 confocal microscopes. The area of mesenteric tumors
was determined by analysis of images from H&E-stained sections
using ImageJ (Schneider et al., 2012). The cross-sectional tumor
area corresponding to the hypoxic threshold was calculated to be
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<104,000µm2 based on the diameter of the spheroid in Figure 7B
(364µm).
TRANSMISSION ELECTRON MICROSCOPY
Tissue was collected and fixed in 2% glutaraldehyde, post-fixed
with osmium tetroxide, dehydrated in ascending alcohols, and
embedded in Epon. Ultra-thin sections were stained and imaged
on a Hitachi H600 transmission electron microscope (TEM). To
identify SKOV3.ip1 cells present in tissue samples, their character-
istic nuclear ultrastructure was determined from high magnifica-
tion TEM images taken of SKOV3.ip1-GFP cells grown as 5,000
cell spheroids in a U -bottom Lipidure-coated 96-well plate (NOF
America, Irvine, CA, USA) for 48 h.
THE OVARIAN TUMOR MODEL
We based our model on the following set of major assumptions
that are inspired by the biology and empirical data.
1. The three-dimensional (3-D) tissues we model consist of ovar-
ian tumor (SKOV3.ip1), mesothelial, adipocyte, endothelial,
and smooth muscle cells, as well as ECM fibers and peritoneal
fluid.
2. Adhesion strengths between various cell types are prescribed
and remain constant, e.g., adhesion between SKOV3.ip1 cells is
stronger than between SKOV3.ip1 and mesothelial cells.
3. The chemical environment consists of oxygen, tumor-secreted
VEGF, adipocyte-secreted IL-8 (Nieman et al., 2011), and
another unidentified growth factor (Growth Factor 2) secreted
by blood vessels.
4. Both IL-8 and Growth Factor 2 are chemoattractants for
tumor cells. VEGF is a chemoattractant for endothelial cells.
Chemotaxis speed is proportional to the chemical gradient.
5. Cells consume oxygen supplied by the peritoneal fluid and
blood vessels. When oxygen levels are below a threshold value
(20 mm Hg), tumor cells become hypoxic and stop growing.
They resume proliferation if oxygen rises above the threshold
level.
6. Cells are required to approximately double in volume
before dividing and their division times have a Gaussian
distribution.
7. Ovarian tumor model does not represent the flow of peri-
toneal fluid (or ascites). Because the diffusion process for all
chemicals considered in our study is much faster than the
cellular processes under consideration, chemicals are well-
mixed. Therefore, it is reasonable to omit convective delivery
of chemicals in this model.
8. Cells can become immobilized if we impose shape constraints.
Addition of a surface area constraint as well as a high volume
constraint can make cells insensitive to changes in adhesion
and to low chemotaxis constants. Adhesion parameter sensi-
tivity analysis was therefore conducted without a surface area
constraint on the cells. This constraint was added after adhe-
sion optimization to produce cells that were more spheroidal,
as they are seen in vivo.
The 3-D ovarian tumor growth and invasion model, OvTM,
is based on the cellular Potts model framework using Compu-
Cell3D (Cickovski et al., 2007; Swat et al., 2009). Ovarian cancer
cells growing in the peritoneum were simulated using parameters
obtained from the mouse model and from published data. Para-
meters for the SKOV3.ip1 cells, endothelial cells, oxygen, growth
factors, and measurements of mouse peritoneal tissue are shown
in Table 1.
In the OvTM, five cell types are considered: ovarian tumor
(SKOV3.ip1), mesothelial, adipocyte, endothelial, and smooth
muscle. ECM fibers and peritoneal fluid are represented as special
types. This cell-based model describes cell growth, division, death,
and chemotactic migration within a 3-D tissue environment that
mimics the specific organ site.
Cells are domains on a 3-D lattice. Each cell has an ID number,
S, on each lattice site i of the cell domain, and an associated cell
type τ. Cell–cell and cell–environment interactions are specified
by an “effective energy”:
H =
∑
i,j
Jτ (Si) , τ
(
Sj
) [
1− δ (Si , Sj)]
+
∑
S
λ
[
V (S)− V t (S)]2 +∑
i
µCi . (1)
The parameter J describes the cell-type-dependent adhesion.
Adhesion coefficients (J ) for the cell types in each model are listed
in Tables 2 and 3. The Kronecker delta function δ ensures no
energy is within cells where ID numbers are the same, limiting
adhesion to cell boundaries. A cell’s volume V is elastically con-
strained to Vt, the target cell volume; Vt is constant for the tissue
cells, but is set to increase linearly for proliferating cells. µ is the
chemical potential describing the strength of chemotaxis, and C is
the chemical concentration at the cell. This term applies to cancer
and endothelial cells when their respective chemoattractant signals
are above threshold activation values.
A modified Metropolis algorithm was used to simulate cell
dynamics. A cell boundary lattice site is selected at random; the
cell number, S, is copied to an unlike neighbor site S′ (selected
at random). This copying corresponds to the cell S protruding a
unit volume into the neighboring cell S′. The difference between
the effective energies before and after the protrusion event, E,
determines if this copying event will be accepted. If the energy
decreases, the protrusion is accepted; if it increases, the protru-
sion is accepted with a Boltzmann probability, exp(−E/T ). The
effective temperature, T, describes the amplitude of cytoskeletal
fluctuation (Mombach et al., 1995). By such microscopic mem-
brane protrusion and retraction, the cells perform biased random
walks, and rearrange themselves, within the constraints of their
volumes and chemical guidance.
Chemical dynamics
Chemical dynamics are evaluated through continuous diffusion
equations and are considered well-mixed in the peritoneal fluid.
Chemicals acting as chemoattractants to SKOV3.ip are: adipocyte-
secreted IL-8 (Nieman et al., 2011), and an unidentified growth
factor secreted from the vessel (Growth Factor 2). The chemoat-
tractant for endothelial cells during angiogenesis isVEGF. A system
of partial differential equations describes the chemical dynamics,
including diffusion through tissues, growth factor decay, glucose
and oxygen consumption, and cell-uptake of signal molecules.
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Table 1 | OvTM parameters.
Value Units Source
CHEMICAL FIELDS
O2 concentration (blood and peritoneal fluid) 98.5 mm Hg Shirasawa et al. (2003), Kizaka-Kondoh et al. (2009)
O2 diffusion (DO2 ) 84,000 µm
2/min MacDougall and McCabe (1967)
VEGF diffusion (DV) 600 µm2/min Serini et al. (2003), Bauer et al. (2009)
VEGF decay (γV) 0.01083 /min Serini et al. (2003), Bauer et al. (2009)
VEGF secretion: normoxic tumor cell (αV) 3.82×10−7 pg/min/cell Huang et al. (2000)
Chemotactic Factor 2 diffusion (DC2 ) 700 µm
2/min e Serini et al. (2003), Bauer et al. (2009)
Chemotactic Factor 2 decay (κC2 ) 0.01083 /min e Serini et al. (2003), Bauer et al. (2009)
Chemotactic Factor 2 secretion (αC2 ) 1.8×10−4 pg/min/cell e Serini et al. (2003), Bauer et al. (2009)
IL-8 diffusion (DC1 ) 15000 µm
2/min Li Jeon et al. (2002)
IL-8 decay (equal to VEGF) (ρC1 ) 0.01083 /min e as in Jain et al. (2008)
IL-8 secretion by visceral adipocyte (αC1 ) 2.2×10−4 pg/min/cell Bruun et al. (2004)
IL-8 background concentration (peritoneal fluid) 1.732 pg/ml Barcz et al. (2002)
METABOLIC PARAMETERS
O2 consumption: proliferating cancer cell (ε) 4.93 fmoles/min/cell Freyer and Sutherland (1985), Casciari et al. (1992)
O2 threshold for hypoxia and VEGF production 19 mm Hg Höckel and Vaupel (2001), Evans et al. (2006),
Shirinifard et al. (2009)
VEGF activation threshold for angiogenesis 0.0001 pg/cell volume e
VEGF deactivation threshold for angiogenesis 0.00002 pg/cell volume e
RATE PARAMETERS
SKOV3.ip1 invasion speed 10 µm/h e from Iwanicki et al. (2011)
Rate of ECM degradation 0.55 µm2/min Bauer et al. (2009)
SKOV3.ip1 cell cycle duration 25.5±1 h m
Vascular endothelial cell cycle duration 24±1 h Ausprunk and Folkman (1977), Levine et al. (2001),
Bagley et al. (2003)
Cell volume after division 96±17 % e from m
MORPHOMETRIC PARAMETERS
Cancer cell radius 3.50 µm m
Average adipocyte cell radius 10.1 µm m
ECM (extracellular matrix) thickness 2 µm m
ECM collagen fiber radius 1 µm m
ECM collagen fiber length 20 µm e
Vascular endothelial cell diameter (initial size) 10 µm Bauer et al. (2009)
Height of mesothelial cell on mesentery 0.44–2.5 µm m, Khanna and Krediet (2009)
Average distance between adipocytes in the mesentery 0.2 µm m
Values were obtained from direct measurement (indicated by “m”) of tissues and tumors or from previously published work. Where experimental values were not
available, values were estimated for the model (indicated by “e”).
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Table 2 | Combined tension and adhesion matrix for OvTM
simulations of spheroid invasion, growth and angiogenesis.
PF VM PTC SE VW A ECM SM
PF 0 10 10 10 10 10 10 10
VM 10 0 20 20 10 20 0 10
PTC 10 20 0 0 0 3 3 0
SE 9.5 19.5 −0.5 1 0 13 5.5 2.5
VW 10 10 0 0 0 13 0 0
A 3.5 13.5 −3.5 6.5 6.5 13 1 0
ECM 9.5 −0.5 2.5 0.5 −0.5 0.5 1 0
SM 10 10 0 2.5 0 0 0 0
White boxes show adhesion coefficients between cell types (Jij) and green boxes
show adhesion coefficients between cells of the same type (Jii). Gray boxes
show the surface tension values between cell types. Surface tension is defined
as STij = Jij−(Jii + Jjj)/2 (Glazier and Graner, 1993). Negative STij signifies attraction,
and positive STij signifies repulsion. Surface tension= 0 for all STii, but homotypic
adhesion Jii can still be strong. Maximum adhesion is 0. Mesenteric invasion
models contain PF, peritoneal fluid; VM, visceral mesothelium; PTC, proliferating
tumor cells; VW, vessel wall endothelial cells, A, adipocytes; ECM, extracellular
matrix (ECM). Included in the spheroid growth model are: PTC, proliferating can-
cer cell; PF, peritoneal fluid,VM, visceral mesothelium,VW, vessel wall endothelial
cells; ECM, extracellular matrix; SM, smooth muscle. Models with angiogenesis
further include VW, vessel wall endothelial cells; SE, sprouting endothelial cells.
∂C1
∂t
= DC1∇2C1 − ρC1 C1 + αC1δ
[
τ (S) , adipocyte
]
, (2)
∂C2
∂t
= DC2∇2C2 − κC2 C2 + αC2δ [τ (S) , vessel] , (3)
∂V
∂t
= DV∇2V − γV V + αV δ [τ (S) , tumor] , (4)
where C1 is IL-8,C2 is Growth Factor 2,and V isVEGF. These equa-
tions describe diffusion through tissue, decay, and production by
source cells.
Oxygen is delivered by the vessel (see Figure 7) and diffuses
from the peritoneal fluid. Its level is kept constant within the peri-
toneum. Diffusion of O2 through tissue and its consumption by
the cells is described as:
δO2
δt
= DO2∇2O2− ∈ δ [τ (S) , tumor] (5)
Depending on the availability of oxygen in their surrounding
environment, cancer cells have the potential to be proliferating,
quiescent or necrotic. Although the capability for cancer cells to
become hypoxic or necrotic was integrated into the model, the
spheroids we simulated were too small in diameter to develop
internal hypoxia under normal physiological conditions,and never
became hypoxic or necrotic.
The secretion rates for IL-8, VEGF, and Chemotactic Factor
2 were taken from quantitative experiments (or estimated for
Chemotactic Factor 2). Oxygen was kept constant at the simu-
lation boundaries with the value corresponding to the steady-state
oxygen level in the mouse peritoneal fluid (∼98.5 mmHg). Back-
ground IL-8 was also kept constant at the z boundaries, defined
as normal to the mesothelium surface, with the value correspond-
ing to its steady-state concentration in the peritoneal fluid. IL-8
concentration at the x and y boundaries was constant at lev-
els diffusing from the adipocytes. Boundary values of VEGF and
Chemotactic Factor 2 were set to steady-state at 0, as background
values were unknown and the cells generated small, concentrated
fields that reached approximately 0 at the distance of the simu-
lation boundaries. For the diffusion rates of these four chemi-
cals (D > 15µm2/min), CompuCell3D cannot generate boundary
conditions for tissues or cell types, as the necessary solver requires
extra solutions per time step that make running models intractably
slow (e.g., ∼525,000 extra solutions per time step are required
in the case of oxygen, resulting in ∼24 h simulation time/1 min
experimental time simulated). All parameters are listed in Table 1.
The chemotaxis constant for SKOV3.ip1 cell response to IL-
8 was increased until the cells were moving through the IL-8
gradient in mesenteric fat tissue at a rate we derived from the
ovarian cancer spheroid experiments by Iwanicki et al. (2011).
Chemotaxis by tumor cells to Chemotactic Factor 2 coming
from the vessel was tuned to have the same order of magni-
tude of response as to IL-8 (order of magnitude (IL-8 concen-
tration× chemotaxis constant)= order of magnitude (Chemo-
tactic Factor 2 concentration× chemotaxis constant), where the
chemotaxis constant= 1× 1013.
Cell reproduction
In OvTM, the cellular level model and the chemical environment
model are integrated through the choice of a common time-scale.
In the cellular Potts model, each Monte Carlo Step (MCS) cor-
responds to as many cellular protrusion events as the number of
lattice sites in the simulation domain. We define one MCS to cor-
respond to 1 min of real time. The chemical equations (Eqs 2, 3,
and 4) are solved at the time step of 1 min, when the cell lattice
configuration and states are assumed constant. The cells update
their states according to their local chemical concentrations. The
cell lattice is then updated for one MCS assuming chemicals stay
constant. Such iterative feedback and update links the discrete cel-
lular Potts model and the continuous chemical equations together.
Each cell has its own division time and age clock. Division time
for cells is set on a Gaussian distribution; SKOV3.ip1 cells divide
between 24.5 and 26.5 h and endothelial cells divide between 23
and 25 h. A cell divides when two conditions are satisfied: (a) the
cell’s age is greater than or equal to its division time, and (b) the
cell’s volume is greater than or equal to its target volume, which
increases linearly with the cell’s age. When the cell (S) divides, it is
halved into two daughter cells, S and S′.
Tissue microenvironments
The three OvTM model scenarios each represent several cubic
millimeters of peritoneal space, about one third of which is tissue.
(The invasion model is 7.6 mm3 and contains 2.6 mm3 of tissue.)
The rest of the volume is filled with peritoneal fluid present in the
mammalian peritoneal cavity. Cell shapes and sizes were deter-
mined by cell morphometry studies of normal mice, nude mice,
and SKOV3.ip1 xenografts. Thickness of the adipose layer sur-
rounding vessels of the mesentery was taken from the literature.
Tissue rigidity in smooth muscle and adipocytes was estimated
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Table 3 | Exploration of adhesion parameters in spheroids attached to the surface of the small intestine.
Parameters tested Results Spheroid images
2-D (tumor center) 3-D
Low homotypic adhesion and low heterotypic
adhesion to non-tumor cells
By 24 h, tumor cells show reduced volume
and the spheroid is no longer cohesive
Cell type 1 Cell type 2 Adhesion 1⇔2
PTC PTC 20
PTC other 20
other=PF, ECM, VM, and SM
Low homotypic adhesion and high heterotypic
adhesion
By 24 h, the spheroid has fragmented while
the mesothelium has aggregated
Cell type 1 Cell type 2 Adhesion 1⇔2
PTC PTC 20
PTC other Tested 0, 1, 3, and 5
High homotypic adhesion and high heterotypic
adhesion
By 12 h, the spheroid has begun to
disintegrate and the mesothelium has
aggregated at the base of the spheroid
Cell type 1 Cell type 2 Adhesion 1⇔2
PTC PTC 0
PTC other 0
High homotypic adhesion and low heterotypic
adhesion
No surface area constraint
At 24 h, a coherent spheroid with a similar
appearance to the SKOV3.ip1 in vivo tumors
can be seen. The mesothelium remains
intact. However, cells are abnormally
convoluted
Cell type 1 Cell type 2 Adhesion 1⇔2
PTC PTC 0
PTC other Tested 10 and 20
High homotypic adhesion and low heterotypic
adhesion
Additional surface area constraint
This model most closely approximates the
shape of SKOV3.ip1 spheroids and cells
in vivo as shown at 12 h
Cell type 1 Cell type 2 Adhesion 1⇔2
PTC PTC 0
PTC other SeeTable 2
Abbreviations are the same as inTable 2.
based on cell junctions and spacing from EM images of mouse
tissues. The depth of penetration of SKOV3.ip1 cells on both tis-
sue types was based upon xenograft tumors in our microscopic
images.
The tissue microenvironments we considered were the outer
surface of the intestine (Figures 2 and 7) and the mesentery
(Figure 5). A layer of mesothelium covers both surfaces. Both
environments are initialized with a tumor spheroid of seven cells
contacting the center of the contiguous mesothelial surface in the
peritoneal cavity.
On the intestine, smooth muscle lies beneath the mesothelium,
separated from it by a thin layer of ECM. Ovarian cancer cells can
push aside the mesothelium and degrade ECM (Kenny et al., 2008;
Sodek et al., 2008), but strong adhesion between the muscle cells
prevents further invasion. Scattered blood vessels lie just below
the mesothelium. In our model, initiation of angiogenesis was
triggered by a threshold VEGF level. When the local VEGF con-
centration exceeds a threshold, endothelial cells lining the blood
vessels begin to proliferate and migrate, organizing into vascular
sprouts.
Tumors on the omentum or mesentery can invade through the
mesothelium and migrate through the loose matrix and adipocyte
fields below. On the mesentery, ovarian cancer cells adhering to
the mesothelium push past the mesothelial cells as chemotactic
gradients originating from adipocytes and vasculature stimulate
migration into the tissue.
Both models are initialized with a tumor spheroid of seven cells
contacting the center of the contiguous mesothelial surface in the
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peritoneal cavity. We assume ECM degradation rate by SKOV3.ip1
tip cells at the invading front is the same as the degradation rate
by endothelial cells at the sprout tip (Bauer et al., 2009).
The process of angiogenesis is driven by endothelial cell chemo-
taxis toward VEGF, and by differential adhesive interactions
between endothelial sprout cells and cancer cells. This simple
model suggests that, to produce vasculature morphology simi-
lar to that in very small xenograft tumors, latent endothelial cells
must become proliferating endothelial cells and initiate angio-
genic behavior as soon as the spheroid comes within diffusion
distance for low concentrations of VEGF of the vessel. Given VEGF
production of 3.82× 10−7 pg/min/SKOV3.ip1 cell, the threshold
for the switch from latent to sprouting endothelial cells is set at
2.08× 10−8 pg/cell volume, which initiates angiogenesis when the
spheroid is about 5µm from the vessel.
Exploration of adhesion parameters
To reproduce the morphology of in vivo SKOV3.ip1 xenografts
on the intestine, we tested four combinations of homotypic and
heterotypic adhesion parameters (Table 3). Only when tumors
were parameterized to have high homotypic adhesion between
cancer cells along with low heterotypic adhesion between cancer
cells and components of the microenvironment (peritoneal fluid,
ECM, visceral mesothelium, and smooth muscle cells) did can-
cer cells form rounded spheroids similar to those seen in vivo. A
surface area constraint was also imposed on the cancer cells to
maintain cell integrity. We ran at least five replica simulations for
each parameter set, and observed no qualitative differences, within
small variations, in our results.
RESULTS
SKOV3.ip1 OVARIAN CANCER CELLS ADHERE TO THE SURFACE OF
NUMEROUS ORGANS IN THE PERITONEUM AND FORM LARGE TUMORS
BY 2WEEKS POST-INJECTION
To recapitulate the essential steps in ovarian cancer relapse
from minimal residual disease in the peritoneum, five million
SKOV3.ip1 human ovarian cancer cells expressing GFP were
injected into the peritoneum of nude mice as a single cell suspen-
sion. Mice were euthanized after 2 weeks and mounted on the stage
of an OV100 fluorescence imaging system. As shown in Figure 1A,
macroscopic tumors developed on numerous organs in the peri-
toneum during this period. The main sites of attachment were the
omentum (Figures 1A,B), the surface of the stomach (Figure 1C)
and small intestine, the mesentery (Figure 1D) and the spleen
(Figure 1E). Tumors also developed on the liver in half of the
mice examined. The largest tumors grew from the omentum and
expanded into the peritoneum, reaching volumes up to 200 mm3
by 2 weeks. Even within this short time frame, the tumors are well
vascularized with vessels penetrating and wrapping around the
outside of the largest tumors. Many smaller tumors can be found
attached to the mesentery, often visible to the naked eye, ranging
in size from 0.4µm3 to 1 mm3.
STRONG HOMOTYPIC INTERACTIONS DRIVE SKOV3.ip AGGREGATION
It has been hypothesized that ovarian cancer cells aggregate and
form spheroids when suspended in peritoneal fluid and that these
spheroids then attach to the peritoneal surface and form large
tumors (Shield et al., 2009). To test this hypothesis and to assess the
clonality of the tumors at distinct sites, a mixture of SKOV3.ip1-
GFP and SKOV3.ip1-RFP cells were co-injected into nude mice as
a single cell suspension. The resulting tumors were imaged 2 weeks
later. Tumors on the omentum developed as well-mixed chimeras,
with both green and red fluorescence throughout (Figures 2A,B).
In higher magnification images, small areas with predominantly
red fluorescence can be distinguished from areas with predomi-
nantly green fluorescence, but there are no large sections of tumor
expressing a single fluorescent protein (Figure 2C). The major-
ity of the observed mesenteric tumors (92± 2% of 51 observed
tumors) also have mixed green and red fluorescence, indicating
that even these small tumors originated from a mixed spheroid
(Figures 2D,E). The few small tumors consisting solely of GFP-
positive or RFP-positive cells may represent rare instances where a
single cell, or a small group of singly fluorescent cells, was able to
adhere and grow (Figure 2E, arrow).
These data provided the first essential parameters for initial-
ization of our OvTM mathematical model, since adhesion is a
predominant feature of the cellular Potts framework (Graner and
Glazier, 1992). Simulations were initiated with an adherent spher-
oid on the surface of the intestine. The spheroid subsequently
pushes through the mesothelium. This process has been observed
in vitro, where tumor spheroids cause retraction of the mesothe-
lium using a myosin-mediated process (Iwanicki et al., 2011).
The in silico experiments using OvTM showed that only by
assigning high homotypic adhesion strength to the cancer cells
could the model reproduce spheroid cohesiveness and growth
(Figure 2F). For details on how the adhesion parameters were
optimized, see Section “Materials and Methods” (Table 3). Simu-
lations in which cancer cells adhered more strongly to other cancer
cells than to any other cell type, produced the most rounded tumor
morphology that closely resembled the xenograft tumors. Adding
a cellular surface area constraint maintained the integrity of the
cells themselves. Since the model indicated that tumor cell homo-
typic adhesion is an essential feature governing dissemination and
growth, this concept was further tested experimentally by sequen-
tially introducing fluorescent cancer cells into the peritoneum
(Figure 3). In this experiment, tumors were first established by
injection of 2.5 million SKOV3.ip1-GFP cells. After a period of
1 week to permit engraftment of the green-fluorescent cells, an
equal number of SKOV3.ip1-RFP cells were injected. Follow-
ing another week, the relative distribution and burden of both
green and red fluorescent tumor cells were evaluated. As expected,
SKOV3.ip1-GFP tumors formed on the omentum, mesentery, and
spleen. Notably, the majority of red fluorescent cells adhered
to and enveloped the pre-existing GFP-positive tumors as can
be seen on the omental tumors (Figure 3A) and on the spleen
(Figure 3B), rather than forming tumors independently. Although
some exclusively RFP-positive tumors were present on the mesen-
tery (Figure 3C, arrows), 70% of the 24 RFP-positive tumors
examined were also GFP-positive.
TUMOR CELLS MIGRATE THROUGH THE OPEN ARCHITECTURE OF THE
MESENTERY IN RESPONSE TO CHEMOTACTIC SIGNALS
Our next goal was to identify specific features of the microenvi-
ronment that underlie differences in ovarian tumor morphology
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FIGURE 1 | SKOV3.ip1-GFP cells colonize the surface of many
organs in the mouse peritoneum. (A) Image of SKOV3.ip1 tumors
growing from the omentum (large central tumor, arrowhead), the
intestine, attached mesentery (white arrows), and the liver (yellow
arrow) of an RFP nude mouse. Tumors on the spleen are not visible in
this image. (B)The largest tumors are attached to the omentum located
on the larger curvature of the stomach and are well vascularized. (C)
Tumors attached to the stomach are spherical and non-invasive. (D) On
the mesentery, small tumors are located adjacent to major blood
vessels (arrow). (E) Small tumors growing on the spleen have a flatter,
sponge-like morphology with less well defined borders between the
tumor (green) and the normal tissue.
by examining the structure of external tissue layers facing the peri-
toneum. Both normal and tumor-associated tissues were extracted
and prepared for TEM imaging. The micrograph in Figure 4A
illustrates the open architecture of the normal mesentery, with
loosely packed fat cells below the mesothelium. The mesothelial
layer is remarkably thin in some areas, ranging from 0.4 to 2.5µm
in thickness. A second image (Figure 4B) shows a cross-section of
mesentery excised from mice engrafted with SKOV3.ip1 human
ovarian cancer cells. Labels mark the locations of probable tumor
cells, identified by the characteristic ultrastructure of their nuclei.
The tumor cells are interior to the mesothelium and adjacent to a
small blood vessel.
To understand how tumors are established in the mesentery,
SKOV3.ip1-GFP cells were injected into the peritoneum and 4 days
later segments of the mesentery were removed for whole mount
imaging. As shown in Figures 4C,D, images from this early time
point provide a window into the initial steps in the engraftment
process. Small groups of fluorescent cancer cells were seen within
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FIGURE 2 | Co-injected SKOV3.ip1-GFP and RFP cells yield chimeric
tumors. Equal numbers of SKOV3.ip1-GFP and SKOV3.ip1-RFP cells
were injected as a single-cell suspension into the peritoneum of nude
mice. (A–C) Large tumors on the omentum are both GFP-positive
(GFP-filter) (A) and RFP-positive (RFP-filter) (B). White boxes: magnified
region shown in (C). (C) A 5X magnified composite image of the tumor
from (A,B) showing a mixture of GFP- and RFP-positive cells. (D,E)
Chimeric tumors on the mesentery have patches of green and red
fluorescence. A clonal tumor that is only GFP-positive can be seen (E),
(arrow). (F) Endpoint of a mathematical simulation initialized with a
mixed GFP/RFP spheroid of 56 cells attached to the mesothelial surface
of the intestine. A 180×180×180µm lattice (5.832 mm3) is partitioned
into layers of smooth muscle (brown), extracellular matrix fibers (teal),
mesothelium (dark blue), and vessel (red) creating a 0.84 mm3 tissue
layer. Above the tissue is peritoneal fluid. The 3-D image shows a
chimeric tumor (orange and green cells) after 7 days of growth.
the mesenteric adipose layer (Figure 4C) or beneath the adipose
layer immediately adjacent to vessels (Figure 4D).
We next used OvTM to evaluate the conditions necessary for
cancer cells to migrate to mesenteric vessels within this short
time period. The cellular Potts model is particularly well suited
for this type of modeling, since it specifically represents cell–cell
interactions and cell movement, which is governed by local con-
tacts and chemotactic gradients. The 3-D stochastic model was
populated with heterogeneous cell types (cancer cells, adipocytes,
endothelial cells, and mesothelium) and geometric features (shape,
location, organization, and thickness of tissue layers) based on
TEM images. Extracellular factors, such as chemokines and oxy-
gen, are described by diffusion equations with sources and sinks.
In each case, cancer cells push through the mesothelial layer and
degrade the underlying ECM, as shown experimentally (Sodek
et al., 2008). Simulations can then demonstrate the extent of tumor
invasion in response to different chemotactic environments.
Figure 5 shows results from three scenarios that were consid-
ered in these simulations. Movies for representative simulations
are provided in Supplementary Data (Movies S1–S3 in Supple-
mentary Material). For each case, a spheroid of seven cancer cells
was initially positioned on a 3-D geometrical model of the mesen-
tery. Mesothelial cells form the boundary with the peritoneum;
adipocytes are dispersed within the interior, and a single vessel
transverses the tissue.
In the first scenario, there is no local production of chemotac-
tic factors imposed. The spheroid is positioned such that it is in
contact with the ECM. In the absence of chemotactic factors, the
spheroid dissolves the ECM and presses into the adipose tissue after
2 days (Figure 5A). This progression is too slow to explain cancer
cell localization near mesenteric blood vessels in the mouse model.
SKOV3.ip1 cells have been shown to home toward chemokine-
producing adipocytes and upregulate the IL-8 receptor (CXCR1)
when co-cultured with adipocytes (Nieman et al., 2011). There-
fore, in the second scenario, simulation parameters were modified
such that all adipocytes within the mesentery secrete IL-8 at a rate
of 2.2× 10−4 pg/min/cell (Bruun et al., 2004), which diffuses at
1.5× 104 µm2/min (Li Jeon et al., 2002). Cancer cells are then
allowed to chemotax up the resulting IL-8 gradient. In our model,
spheroid invasion of the ultra-thin mesothelium is rapid, occur-
ring at a rate of 10µm/h based upon the in vitro experiments of
Iwanicki et al. (2011). The pseudo-colored image in Figure 5B
shows the predicted distribution of IL-8 in the mesenteric tissue at
steady state, illustrating the initial conditions experienced by the
tumor spheroid. Simulated IL-8 concentrations within the peri-
toneum agree with those measured experimentally (Barcz et al.,
2002). When IL-8 chemotaxis is included in the simulation, the
spheroid moves past the mesentery barrier and pushes between
adipocytes to settle near the center of the adipose layer where
the IL-8 concentration is greatest (Figure 5D). This occurs within
500 min after initialization. In this case, rapid chemotaxis occurs,
but the cancer cells do not localize near the vessel.
In the final case, both adipose and endothelial cells are assumed
to produce chemotactic factors that attract cancer cells. We intro-
duce a new chemotactic factor (Chemotactic Factor 2) that orig-
inates from the mesenteric vessel. Steady-state values represented
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FIGURE 3 | SKOV3.ip1-GFP and RFP cells injected sequentially
emphasize the importance of tumor cell-cell adhesion. About 2.5 million
SKOV3.ip1-GFP cells were injected into nude mice and allowed to grow for
1 week before injection of an equal number of SKOV3.ip1-RFP cells. Tumors
were imaged 1 week later. (A) SKOV3.ip1-RFP cells preferentially adhere to
and coat existing GFP-positive tumors on the omentum. (B) Similar to the
omentum, SKOV3.ip1-RFP cells preferentially adhere to existing GFP-positive
tumors on the spleen. (C) On the mesentery, RFP-positive cells form new
tumors (white arrows) as well as adhering to existing tumors. Int, small
intestine (autofluorescent).
in the pseudo-colored profile in Figure 5C show that a signifi-
cant gradient can be established by endothelial cell secretion of
Chemotactic Factor 2 at a rate of 1.8× 10−4 pg/min/cell, which
is comparable to that of IL-8 secretion from the adipocytes, and
assuming diffusion and decay rates similar to VEGF. When cells
are arranged in this geometry, the presence of both chemotac-
tic gradients causes spheroids to penetrate the mesothelial layer,
move by chemotaxis through the loose adipose layer toward the
vessel, and halt at the tightly adherent barrier of the vessel wall
(Figure 5E). Together with the experimental data, these results
support the conclusion that both adipocytes and endothelial cells
are likely sources of chemokines that attract ovarian tumor cells.
SMALL SKOV3.ip1 TUMORS ATTACHED TO SURFACES OF THE
STOMACH OR SMALL INTESTINE ARE NON-INVASIVE AND INITIATE
ANGIOGENESIS
We next focused on explanations for the distinct morphology of
tumors attached to the stomach or small intestine, which do not
invade the tissue and instead grow outward into the peritoneal
cavity (Figure 6A). We again sought insight from high resolution
TEM images. As shown Figure 6C (mesentery) and Figure 6D
(stomach), the outer mesothelial layer remains relatively thin over
these organs (typically 0.5µ thick). The next layer is distinguished
by dense collagen deposits. Prominent smooth muscle layers can
be seen in both the small intestine and stomach, where the muscle
cells are closely opposed and connected by gap junctions (Friend
and Gilula, 1972) (arrows, Figure 6B).
The morphology of a tumor attached to the outer rim of the
lower intestine is seen at a lower magnification in Figure 6E,
which shows a representative section from a formalin-fixed, paraf-
fin block stained with H&E (hematoxylin and eosin). The smooth
muscle of the small intestine remains intact at the tumor/tissue
interface. Thus, tumors attached to the exterior of the gut are
presented with a discrete barrier and adapt by growth into the
available and flexible space between organs. The intestine has a
capillary bed that provides oxygen to the mesothelium and con-
tributes to the oxygenated peritoneal environment (Figure 6F).
Because of the lack of a smooth muscle barrier, these vessels may
provide a more accessible endothelial source for neoangiogenesis
critical to tumor success.
Microscopic evaluations provide support for this hypothe-
sis (Figures 6B,E). Fluorescence imaging shows the remarkable
extent of tumor vascularization, even in young GFP-positive
tumors attached to the intestinal wall at 2 weeks post-engraftment
(Figure 6B). A red arrowhead in Figure 6E points to a vessel visible
within the tumor cross-section. This evidence led us to conduct
simulations to explain the rapid onset of neovascularization in the
absence of invasion.
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FIGURE 4 | Four days post-injection, tumor cells have invaded the
mesentery and migrated through adipose tissue to approach mesenteric
blood vessels. (A)Transmission electron micrograph of the edge of the
mesentery from a nude mouse. The mesentery architecture is open with
loosely connected adipose cells below the mesothelium. Adipocytes are
identified by their large lipid droplets. (B)Transmission electron micrograph of
mesentery excised 4 days post-injection of SKOV3.ip1 cells. Arrows mark the
locations of probable cancer cells. The cancer cells lie close to a blood vessel.
(C) Cancer cells invading mesenteric adipose tissue adjacent to a vessel. On
the right, GFP fluorescence of the cancer cells; middle, brightfield; left,
composite image. (D) Cancer cells closely opposed to a mesenteric vessel.
Panels are arranged as in (C).
SKOV3.ip1 TUMOR SPHEROIDS ARE INITIALLY WELL OXYGENATED AND
LIKELY INDUCE NEOVASCULARIZATION VIA CONSTITUTIVE SECRETION
OF ANGIOGENIC FACTORS
For the in silico model of angiogenesis, micron-scale geometric
parameters for the tissue surface architecture were again deter-
mined from TEM images. For the gut, adhesion between smooth
muscle cells is set sufficiently high as to prevent spheroid pen-
etration below the mesothelial and collagen layers. Under these
constraints, simulations of tumor adhesion and growth result in
the formation of spherical tumors that are consistent with the
morphology of engrafted tumors on mouse intestine (compare
Figures 6A and 7C). Since these simulations incorporate pub-
lished values for oxygen content in the peritoneal fluid and oxygen
diffusion rate (MacDougall and McCabe, 1967; Kizaka-Kondoh
et al., 2009), it is possible to calculate the distribution of oxy-
gen in all locations during tumor growth. By coarse-graining the
model (1 voxel= 1 cell), we were able to determine the oxy-
gen concentration gradients for large spheroids suspended in
the peritoneal fluid. In spheroids of varying sizes, oxygen con-
centration decreased within the core. However, spheroids up to
336µm in diameter (58,000 cells) approach the hypoxic thresh-
old of 19 mm Hg of O2 (Höckel and Vaupel, 2001), but are
not yet hypoxic at their core (Figure 7A). Continued growth to
364µm in diameter (74,000 cells) results in a hypoxic core with
an oxygen concentration of 0.5 mm Hg (Figure 7B), leading to
the prediction that the hypoxic threshold is reached when the
spheroid is between these two sizes. Tumor sizes in mouse sam-
ples were compared based on the cross-sectional area of tumors
in H&E-stained sections. Mesenteric tumor vascularization with
respect to tumor area is shown as scatter dot plots in Figure 7E.
Of the 76 tumors measured, all tumors above the predicted
hypoxic threshold (red) were vascularized. However, 57% of small
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FIGURE 5 | 3-D simulations of cancer cell attachment and
migration to the mesenteric vessel. (A)The initial configuration of the
simulation has a seven-cell spheroid attached to the surface of the
mesentery. To model this environment, a 170×170× 263µm lattice
(7.6 mm3) is partitioned into five layers of adipocytes (light blue)
sandwiched between single layers of mesothelium (dark blue) and
ECM (teal) creating a 2.6 mm3 tissue layer surrounded by peritoneal
fluid. A blood vessel on the right is represented by a solid rod (red). In
the absence of chemotactic signals, the spheroid penetrates only the
thin mesothelial layer at 1–2 min of simulation. (B,C) Steady-state
distributions of chemotactic factors tested in these simulations. The
color scale represents variation in factor concentrations in ng/ml. (B)
The IL-8 gradient created by secretion of IL-8 from adipocytes. (C) A
chemotactic gradient based on secretion of a hypothetical chemotactic
factor (Chemotactic Factor 2) from mesenteric vessels. (D) Sequences
in the simulation where a chemotactic gradient based on IL-8 is
originating from the adipocytes. The spheroid migrates toward the
center of the adipose layer. (E) Sequences of a simulation where
chemotactic signals originate from both the adipocytes and the vessel.
The spheroid migrates through the adipose layer toward the vessel.
tumors with an area of <104,000µm2 (below the predicted
hypoxic threshold) were also vascularized. These results suggest
that angiogenesis is not solely hypoxia-driven in the SKOV3.ip1
model.
In the next series of simulations, we examined how angio-
genesis might originate from these spheroids in the absence of
hypoxic signaling. There is experimental evidence that SKOV3.ip1
cells constitutively express VEGF in vivo and in vitro even when
maintained in well-oxygenated tissue culture conditions (Yoneda
et al., 1998). Secretion of VEGF by the cancer cells was therefore
incorporated into these simulations. Small spheroids attached to
the gut penetrate the mesothelial layer, permitting VEGF secreted
from cancer cells to initiate chemotactic gradients and attract
endothelial cells that line blood vessels in the sub-mesothelial layer.
The process of angiogenesis is driven by endothelial cell chemo-
taxis toward VEGF, and adhesive interactions between endothelial
sprout cells and cancer cells. To produce vasculature visually sim-
ilar to that in very small xenograft tumors, latent endothelial
cells must begin to proliferate and migrate as soon as the spher-
oid comes close enough to the vessel to allow diffusion of low
concentrations of VEGF. Given spheroid VEGF production of
3.82× 10−7 pg/min/SKOV3.ip1 cell, the threshold for the switch
from latent to sprouting endothelial cells was set at 2.08× 10−8,
to initiate angiogenesis when the spheroid is ∼5µm from the
vessel.
Angiogenesis in the OvTM model follows validated methods
that treat VEGF as diffusible molecules whose gradient, together
with the biophysical environment, drives endothelial migration
and proliferation, and eventually morphogenesis of vessel sprouts
(Bauer et al., 2007; Shirinifard et al., 2009). Parameters and model
assumptions are described in the Materials and Methods. Sim-
ulation results show that constitutive production of VEGF from
even a small spheroid of SKOV3.ip1 cells should be capable of
initiating vascular outgrowths that penetrate the spheroid within
12 h of attachment (Figure 7D; Movie S4 in Supplementary Mate-
rial). Results of the computational model are consistent with our
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FIGURE 6 |Tumors that adhere to the walls of the small intestine are
spherical and non-invasive. (A) An SKOV3.ip1-GFP tumor adhering to
the wall of the small intestine 2 weeks post-injection in an RFP nude
mouse. Shown is a composite GFP/RFP image. Small vessels are visible
on the surface of the tumor. (B) Higher magnification image of the
vascular tree infiltrating a green-fluorescent tumor on the intestine. (C)
Transmission electron micrograph of the small intestine wall. Tissue was
collected from a nude mouse 4 days post-injection with SKOV3.ip1-GFP
cells. The wall of the small intestine consists of a thin layer of
mesothelium overlaying bundles of smooth muscle fibers. (D)TEM
image of stomach ultrastructure, illustrating the distinct cellular layers.
(E) An H&E-stained section of a tumor attached to the small intestine.
There is a clear delineation between the intestine and the tumor. The
tumor is vascularized (red arrowhead). (F). An H&E-stained section of the
surface of a mouse intestine. Arrow points to vessels at the
intestine-mesentery junction.
experimental observations that even very small tumors, com-
prised of less than 20,000 SKOV3.ip1 cells, are fully vascularized
(Figure 7F). They are also consistent with 3-D images of tumor
slices stained for confocal fluorescence imaging that show exten-
sive tumor vascularization 3 weeks post-injection (Figure 7G). In
this final image, an anti-CD31 antibody (red) marks endothelial
cells, Hoechst (blue) stains the cell nuclei and an anti-GFP anti-
body (green) labels the GFP-positive cancer cells. A rotating 3-D
view of this tumor section is found in Movie S5 in Supplementary
Material.
DISCUSSION
In this work, we combine a murine xenograft model with a com-
putational model, OvTM, to evaluate critical factors governing
the dissemination and growth patterns of ovarian cancer in the
peritoneum. These models best represent ovarian cancer relapse
after debulking surgery, where disease progression initiates from
microscopic residual disease in the peritoneal chamber.
In cellular Potts models, the variety of constraints placed on
cells must be properly balanced to produce biologically reason-
able cellular and tissue structure and movement. We quantitatively
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FIGURE 7 |Vascularization of tumors is rapid and can be attributed to
constitutive release of angiogenic factors by SKOV3.ip1 cells. (A,B)
Representations of the steady-state oxygen gradients from coarse-grained
simulations of spheroids suspended in peritoneal fluid. The color scale
indicates the range of oxygen concentrations in mm Hg. Black circles mark
the perimeter of the spheroids. (A)The oxygen gradient through the middle
of a spheroid 336µm in diameter (58,000 cells). At this size, all cells are well
oxygenated with an oxygen partial pressure above the hypoxic threshold of
19 mm Hg (indicated on the color scale as a blue arrow). The lowest oxygen
concentration at the core of the spheroid is 21.6 mm Hg. (B)The oxygen
gradient through the middle of a spheroid 364µm in diameter (74,000 cells).
By the time a spheroid has reached this size, the core is hypoxic (0.5 mm
Hg). (C,D) OvTM simulations of angiogenesis in a tumor attached to the
intestinal wall, assuming constitutive release of VEGF from cancer cells.
(C) 3-D image of the simulation after 7.8 days when the tumor has grown to
6,400 cells. (D) 2-D slice through the middle of the tumor in (D) to show
vessel tree morphology. (E) Scatter dot plots of mesenteric tumor
vascularization with respect to cross-sectional tumor area as determined
from H&E-stained sections of mouse intestine and mesentery collected
3 weeks post-injection. Areas of all mesenteric tumors measured are plotted
on the left. Tumors with areas above the predicted hypoxic threshold are in
red. All non-vascularized tumors fall below the hypoxic threshold. The right
plot shows the area and vascularization status of small tumors that fall
below the hypoxic threshold. A majority of these small tumors (57%) are
also vascularized. Lines indicate the median value. (F) Cross-sectional view
of a small mesenteric tumor after H&E staining. Red blood cells (red) can be
seen populating vessels within the tumor (blue). (G) Confocal image of
ovarian tumor removed from the surface of the gut and labeled with
anti-CD31 antibody (endothelial cell marker, red fluorescence) to distinguish
tumor vasculature. An anti-GFP antibody with an FITC-labeled secondary
antibody marks GFP-expressing cancer cells; Hoechst (blue fluorescence)
labels the nuclei of all cells in the field of view.
modeled oxygenation in a simple spheroid to estimate at what
diameter the tumor center would become hypoxic, for compari-
son with diameters of vascularized tumors observed in the mouse
xenografts. Cancer cell homotypic and heterotypic adhesions on
smooth muscle were then tuned to regenerate the spheroidal mor-
phology of SKOV3.ip1 xenograft tumors on the small intestine
or stomach (Figure 6A). To simulate the depth to which spher-
oids penetrate in soft tissue due to a chemotactic motive force, the
underlying tissue structure was adjusted to represent a fatty section
of the mesentery. In the simulations, tumors remain on the surface
of smooth muscle, a tissue with many underlying tight junctions
(Figures 6C,D), and invade soft tissues with space between cells,
such as the mesentery (Figure 4A).
Finally, we simulated VEGF-driven angiogenic morphogenesis
borrowing from previous methods using cellular Potts models for
tumor-driven angiogenesis (Bauer et al., 2007, 2009; Shirinifard
et al., 2009), in which endothelial cell chemotaxis toward soluble
VEGF leads to angiogenic sprouting and branching. These models
treated VEGF as a diffusible molecule whose gradient, together
with the biophysical environment, drives endothelial migration
and proliferation, and eventually morphogenesis of vessel sprouts.
We did not include other angiogenesis dynamics from Bauer et al.
(2009), which considered endothelial cell interactions with the
ECM to further drive sprouting morphogenesis, nor does our
model assess tumor growth as in Shirinifard et al. (2009), which
modeled tumor growth in response to a growing network of sur-
rounding vessels providing nutrients. Instead, angiogenesis was
modeled as a simple morphogenetic process driven by chemotaxis
and differential adhesion that penetrates a 3-D tumor. The sprout-
ing vessel’s base cell (or cells) has a semi-permanent elastic bond
to the existing vessel, describing the labile adhesion interactions
between them. Otherwise, differential adhesions between tumor
and endothelial cells facilitate endothelial sprouting up the VEGF
gradient.
The basic OvTM model and parameter set remain the same for
all three groups of simulations (spheroids on muscle, spheroids
invading mesenteric fat, and angiogenic sprouts in spheroids on
muscle), except for the following: Between the cases of spheroid
growth in different niches, the tissue surface is comprised of dif-
ferent cell types with their associated parameters. In angiogenesis
simulations, the volume constraint for cancer cells was increased to
help prevent cell fragmentation during migration. Constraints on
endothelial cells in the angiogenesis model (proliferating endothe-
lial, non-proliferating endothelial, and permanent vessel) include
elastic labile adhesion bonds between each type of vascular cell and
its neighbors. The CC3D simulation code will be available upon
request to the authors.
We show that, for the aggressive SKOV3.ip1 cell line, homotypic
adhesion between cancer cells is a defining feature that favors the
aggregation of cancer cells into small spheroids. The spheroid mor-
phology may promote adhesion-mediated cell survival signals and
allow cancer cells to evade anoikis, a cell death program usually
triggered by loss of cell adhesion to the ECM (Kim et al., 2012).
We speculate that these strong homotypic interactions may help
to explain the typical clinical presentation where ovarian cancer
is largely confined to the peritoneum and often accompanied by
ascites. It is notable that others have shown spheroids are less sus-
ceptible to chemotherapeutic agents and may therefore contribute
to relapse (Shield et al., 2009).
While some treatment regimens have focused on reducing
metastatic spread through limiting cancer cell adhesion to the
mesothelium (Sawada et al., 2012), we were interested in whether
interactions between cancer cells might also be an important
target. Using serial injections of green-fluorescent and red-
fluorescent cells, we demonstrated that newly introduced cancer
cells preferentially adhere to existing tumors. Strong cell-cell adhe-
sion between cancer cells that stabilizes tumor clusters in the
simulations could explain this observation. However, autocrine
factors may also contribute to cancer cell homing, similar to the
release of IL-6 and IL-8 from breast tumors that draws circu-
lating tumor cells back to the primary tumor site (Kim et al.,
2009). Although the mechanism is not well understood, thera-
pies targeting ovarian cancer cell-cell homotypic adhesion may
be worth consideration. In addition to limiting tumor mass, such
drugs might be administered in combination with conventional
chemotherapy to improve drug penetration.
Distinct niches within the peritoneal microenvironment also
help to restrict cancer cells to the peritoneum and limit metastatic
spread to other anatomical sites. Based upon the animal and math-
ematical models, colonization and growth is favored in loosely
organized tissues. There are similarities between the open archi-
tectures of the mesentery and omentum, two organs that are
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colonized by SKOV3.ip1 cells and share rich beds of adipose tissue
known to secrete cytokines and growth factors attractive to cancer
cells (Collins et al., 2009; Klopp et al., 2012). The adipocyte-rich
omentum has a slightly thicker mesothelial layer than the mesen-
tery, but has stomata or openings in the mesothelium above the
milky spots that expose the underlying layers (Cui et al., 2002). The
open architecture of these organs offers few barriers to cancer cells
that undergo chemotaxis in response to local chemokine produc-
tion. In contrast, even the aggressive SKOV3.ip1 cancer cell line
is largely blocked by physical barriers such as the smooth muscle
layers in the GI tract.
Our work is consistent with recent studies by Nieman et al.
(2011), who showed that SKOV3.ip1 cells adhere to the omentum
as early as 20 min post-injection and migrate in response to IL-8
and other chemotactic agents produced by adipocytes. In addition,
we provide new evidence suggesting that SKVO3.ip1 cells migrate
through the mesothelium and adipose tissue toward mesenteric
vessels. Chemotaxis of cancer cells toward existing vessels has
been observed in rodent models injected subcutaneously with
mammary carcinoma cells (Li et al., 2000). Based on results from
OvTM simulations, we propose that a chemotactic factor originat-
ing from the vessel may mediate this process. Although the identity
of the factor is unknown, it is possible that vessels also produce
an IL-8 gradient that attracts cancer cells, since activated vascular
smooth muscle cells are capable of producing IL-8 (Wang et al.,
1991). Growth factors secreted by perivascular tumor-associated
macrophages, such as the epidermal growth factor (EGF), could
also promote local survival and proliferation of tumors that take
up residence near vessels (Lewis and Pollard, 2006).
Interestingly, rodent models that showed tumor migration to
blood vessels also exhibited early angiogenesis in tumors consisting
of fewer than 300 cells (Li et al., 2000). The constitutive expres-
sion of angiogenic factors by SKOV3.ip1 cells may be the single
most important feature contributing to the aggressive growth of
this cancer cell line after engraftment. In preliminary data not
shown, microarray studies showed that VEGF mRNA levels differ
less than twofold in cultured SKOV3.ip1 cells versus in vivo. In
OvTM simulations, this modest level of constitutive production is
sufficient for even minute tumor spheroids to recruit endothelial
cells from nearby vessels (Figure 7). This result is in contrast to
the classical solid tumor situation, where angiogenesis is initiated
only after the interior tumor cells become hypoxic and upregulate
VEGF production (Shweiki et al., 1992; Pugh and Ratcliffe, 2003).
In patients, however, it is important to note that the balance of con-
stitutive and induced production of angiogenic factors by cancer
cells may vary widely. Therefore, assessment of angiogenic factor
transcriptional profiles or direct measurement of angiogenic fac-
tor levels in serum/cystic fluid may be critical to identify patients
at risk for relapse, a concept that has also been proposed by others
(Harlozinska et al., 2004; Li et al., 2004).
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